Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration-Reference-Cited by-同舟云学术

Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration

Published:2009-07 Issue:7 Volume:70 Page:848-861
ISSN:0002-9645
Container-title:American Journal of Veterinary Research
language:en
Short-container-title:American Journal of Veterinary Research

Author:

Pearson Wendy,Orth Michael W.,Lindinger Michael I.

Publisher

American Veterinary Medical Association (AVMA)

Subject

General Veterinary,General Medicine

Reference38 articles.

1. The Use of Nutraceuticals for Osteoarthritis in Horses

2. Anti-inflammatory and chondroprotective effects of nutraceuticals from Sasha's Blend in a cartilage explant model of inflammation

3. Effects of simulated digests ofBiota orientalisand a dietary nutraceutical on interleukin-1– induced inflammatory responses in cartilage explants

4. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Translational Model for Repeated Episodes of Joint Inflammation: Welfare, Clinical and Synovial Fluid Biomarker Assessment;Animals;2023-10-12

2. What Are Supplements? The Importance of Micronutrients in the Horse’s Diet;Evidence Based Equine Nutrition;2023-09-30

3. Cell morphology as a biological fingerprint of chondrocyte phenotype in control and inflammatory conditions;Frontiers in Immunology;2023-02-13

4. Evaluating the Safety of Intra-Articular Mitotherapy in the Equine Model: A Potential Novel Treatment for Osteoarthritis;Journal of Equine Veterinary Science;2023-01

5. The Biota orientalis, oil extract Epiitalis®, is efficacious at reducing the symptoms of knee osteoarthritis: a pilot, multi-site, dose-ranging, randomized, blinded, placebo-controlled trial;Inflammopharmacology;2022-06-22